From: Novel LC–MS/MS method for analysis of metformin and canagliflozin in human plasma: application to a pharmacokinetic study
Analyte
Q1 (m/z)
Q3 (m/z)
DP (v)
EP (v)
CE (v)
CEP (v)
Metformin
130.2
60.1
26
10
19
12
Canagliflozin
462.3
191.2
61
15
18
Propranolol HCl
260.2
183.0
120
28
Tadalafil
390.2
268.2
73
50
17.4